Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

33 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Recruiting

Whole Body MRI in Oncology

NCT06895291

Conditions
Advanced Breast Cancer, Advanced Prostate Cancer, Blood Protein Disorders, +20 more
Locations
  • IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola Bologna, BO, Italy
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. Meldola, FC, Italy
  • IRCCS Istituto Europeo di Oncologia S.r.l. Milan, MI, Italy
View Trial Details
Active, not recruiting

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT04920084

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, not recruiting

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

NCT04850846

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber at Brighton Brighton, Massachusetts, United States
  • Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States
View Trial Details

Related conditions